Published resolution of Good Manufacturing and Importing Practices for Drugs and Pharmaceuticals Inputs
ANVISA published (May 28) the Resolution RDC No. 392/2020 for defining extraordinary and temporary criteria and procedures for flexing certain specific requirements applicable to the Good Manufacturing Practices and Import of Pharmaceutical Inputs, due to the Coronavirus pandemic. According to the RDC, exceptional and temporally, manufacturers and importers of drugs and pharmaceutical inputs may disregard […]